GG 647 GG 647 (Ramipril 1.25 mg)
Pill imprint GG 647 GG 647 has been identified as Ramipril 1.25 mg.
Ramipril is used in the treatment of high blood pressure; diabetic kidney disease; heart attack; left ventricular dysfunction; heart failure and belongs to the drug class angiotensin converting enzyme inhibitors. There is positive evidence of human fetal risk during pregnancy. Ramipril 1.25 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for GG 647 GG 647 (Ramipril 1.25 mg)
- Imprint:
-
GG 647
GG 647 - Strength:
- 1.25 mg
- Color:
- White & Yellow
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Angiotensin converting enzyme inhibitors
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Sandoz Pharmaceuticals Inc.
- National Drug Code (NDC):
- 00781-2126
- Inactive Ingredients:
- corn starch
gelatin
ferric oxide yellow
sodium lauryl sulfate
titanium dioxide
ferric oxide black
potassium hydroxide
propylene glycol
shellac
ammonia
More resources
Ramipril is associated with the treatment of:
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...

